Differences in cytochrome P450 3A4 (CYP3A4) expression alone do not explain inter-individual variability in CYP3A-mediated hepatic testosterone 6β hydroxylase (TST6βOH) activity

被引：0
|
作者：
Barter, Z. E. [1 ]
Crewe, K. H. [1 ]
Harlow, J. R. [1 ]
Lei, Y. [1 ]
Tucker, G. T. [1 ]
Rostami-Hodjegan, A. [1 ]
机构：
[1] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
129
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [41] Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
    Agrawal, Vishal
    Choi, Ji Ha
    Giacomini, Kathleen M.
    Miller, Walter L.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (10): : 611 - 618
  • [42] The CYP3A4*18 Genotype in the Cytochrome P450 3A4 Gene, a Rapid Metabolizer of Sex Steroids, Is Associated With Low Bone Mineral Density
    Kang, Y. S.
    Park, S. Y.
    Yim, C. H.
    Kwak, H. S.
    Gajendrarao, P.
    Krishnamoorthy, N.
    Yun, S-C
    Lee, K. W.
    Han, K. O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) : 312 - 318
  • [43] Alcohol withdrawal investigation of Cytochrome P450 CYP1A2, CYP2D6, CYP2E1 and CYP3A4 expression and gene polymorphism
    Tascioglu, Nazife
    Saatci, Cetin
    Esel, Ertugrul
    Dundar, Munis
    JOURNAL OF BIOTECHNOLOGY, 2012, 161 : 28 - 28
  • [44] Implications of the disparity in relative holo:apo-protein contents of different standards used for immuno-quantification of hepatic cytochrome P450 3A4 (CYP3A4)
    Wilson, ZE
    Ellis, SW
    Edwards, RJ
    Tucker, GT
    Rostami-Hodjegan, A
    DRUG METABOLISM REVIEWS, 2005, 37 : 77 - 77
  • [45] Functional co-expression of CYP2D6 and CYP3A4 with rat NADPH-cytochrome P450 reductase in S-cerevisiae
    Bandera, M
    Wolf, CR
    Burchell, B
    Friedberg, T
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P335 - P335
  • [46] CYTOCHROME P450 EXPRESSION AND REGULATION IN CYP3A4/CYP2D6 DOUBLE TRANSGENIC HUMANIZED MICE (vol 36, pg 435, 2008)
    Felmlee, M. A.
    Lon, H. K.
    Gonzalez, F. J.
    Yu, A-M
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (07) : 1563 - 1563
  • [47] INTER-INDIVIDUAL VARIABILITY OF CYP1A2, 2B6 AND 3A4 BASAL AND INDUCED ACTIVITY IN PRIMARY CULTURES OF HUMAN HEPATOCYTES
    Zhang, Jin-Gang
    Weng, Yujia
    Picano, Pamela L.
    Liu, Erica
    Clark, Robert J.
    Chandler, Catherine
    Crespi, Charles L.
    Stresser, David M.
    DRUG METABOLISM REVIEWS, 2008, 40 : 100 - 100
  • [48] GENETIC POLYMORPHISMS OF CYTOCHROME P450 (CYP) 2C9, CYP2C19, CYP2D6, CYP3A4, AND CYP3A5 IN A KORSIAN POPULATION
    Lim, Y.
    Kim, E.
    Lee, Y.
    Cha, E.
    Jung, H.
    Kim, J.
    Lee, S.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S61 - S61
  • [49] Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel
    Angiolillo, Dominick J.
    Fernandez-Ortiz, Antonio
    Bernardo, Esther
    Ramirez, Celia
    Cavallari, Ugo
    Trabetti, Elisabetta
    Sabate, Manel
    Hernandez, Rosana
    Moreno, Raul
    Escaned, Javier
    Alfonso, Fernando
    Banuelos, Camino
    Costa, Marco A.
    Bass, Theodore A.
    Pignatti, Pier Franco
    Macaya, Carlos
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) : 1895 - 1900
  • [50] Number of co-administered cytochrome P450 3A4 (CYP3A4) substrates or inhibitors is independent predictor of atherothrombotic events in patients taking clopidogrel
    Sur, Jung-Won
    Koo, Bon-Kwon
    Kwak, Jae-Jin
    Kim, Yong-Seok
    Park, Keun-Ho
    Chung, Woo-Young
    Chae, In-Ho
    Chang, Hyuk-Jae
    Oh, Seil
    Oh, Byung-Hee
    Park, Young-Bae
    Kim, Hyo-Soo
    CIRCULATION, 2006, 114 (18) : 452 - 453
12345